https://www.selleckchem.com/pr....oducts/jr-ab2-011.ht
Conversely, for patients with biallelic CEBPA or DNMT3A mutations, only the MFC method was recommended due to the poor prognostic discriminability in tracking mutant transcripts. In conclusion, this study demonstrated that the MFC MRD after two consolidation cycles independently predicted clinical outcomes, and the integration of MFC and molecular MRD should depend on different types of AML-related genetic lesions. The resection of a motor-eloquent glioma should be guided by intraoperative neurophysiological monitoring (IOM) but its
Like
Comment
Share
